All posts

Follow Us

LinkedInInstagramX
Quarterly ResultsArchiveLast updated 3 November 20262 min read

Chemcrux (CHEMCRUX) Q2 FY27 Profit Jumps 162% as Revenue Growth Returns

The specialty chemicals maker posted a 34% rise in revenue and a 162% surge in net profit for Q2 FY27, though margins remain under pressure.

By Abhinav Singhvi, Founder & CEO Hexawealth · Created 3 November 2026

Chemcrux Enterprises reported a 34.3% year-on-year revenue increase to ₹23.84 crore in Q2 FY27, driving net profit up 161.9% to ₹0.55 crore. Profitability improved from a low base, but margins were flat sequentially amid cost pressures.

For a specialty chemicals maker, the ability to shift production toward in-demand intermediates is the ultimate hedge. Chemcrux Enterprises leveraged this flexibility in the September quarter, posting a sharp recovery from a weak year-ago period.

The company's revenue grew 34.3% year-on-year to ₹23.84 crore. Net profit surged 161.9% to ₹0.55 crore. Sequentially, revenue and profit grew 8.7% and 7.8%, respectively, continuing the momentum from the June quarter.

Revenue & profit

Revenue (₹ Cr)

Profit (₹ Cr)

Net Profit Margin (%)

MetricCurrentQ2 FY27PreviousQ1 FY27Same quarter LYQ2 FY26
Revenue (₹ Cr)
23.84YoY +34%
21.94
17.75
Profit (₹ Cr)
0.55YoY +162%
0.51
0.21
Net Profit Margin (%)
2.3YoY +92%
2.3
1.2

The growth was powered by the company's doubled reaction capacity at its Ankleshwar plant, according to a report by StockScans. This allowed it to meet rising demand for its drug and dye intermediates.

Why Margins Stayed Flat

Despite the sales growth, the net profit margin was unchanged from the previous quarter at 2.3%. A sharp 88.8% year-on-year drop in other income removed a ₹0.55 crore tailwind. Interest costs, though down 25% year-on-year, still consumed a significant portion of operating profit.

The broader chemical industry faced margin pressure. A DCM Shriram earnings call noted production costs rose 6-8% while selling prices fell 4-6% in the September quarter. This squeeze likely limited Chemcrux's ability to convert top-line gains into bottom-line growth.

The Outlook and Market View

Management has not provided explicit financial guidance, notes an analysis by StockFin.ai. The company is in a phase of operational stabilization. Its recent capacity expansion provides a platform, but utilization and pricing will dictate the next leg.

The stock trades at a P/E of 26.1, a 19% discount to the industry average of 32.3. There is no institutional holding, with promoters owning 72.9%. The market seems to be pricing in the volatility typical of a small, promoter-driven chemical player.

Key Points

  • Revenue grew 34% year-on-year, driven by higher volumes from expanded capacity.
  • Net profit jumped 162% from a low base, but the profit margin was flat quarter-on-quarter at 2.3%.
  • A steep decline in other income and industry-wide cost pressures constrained margin expansion.
  • The company is trading at a discount to the sector but lacks analyst coverage and institutional interest.

Hexa Perspective

The quarter shows Chemcrux can grow its top line by leveraging its flexible, multi-chemistry plant. The profit jump is impressive but comes off an exceptionally weak base in Q2 FY26.

The real test is whether it can lift margins back toward the 7%+ levels seen in the second half of last fiscal. That requires either sustained pricing power or a meaningful drop in input costs, neither of which is assured in the current chemical cycle.

Share or follow HexaWealth

Also read

Want this applied to your portfolio?

Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.

Frequently asked questions

What were Chemcrux Enterprises' Q2 FY27 results?
Chemcrux Enterprises reported a revenue of ₹23.84 crore and a net profit of ₹0.55 crore for the quarter ended September 2026. This represents a year-on-year growth of 34.3% in revenue and 161.9% in profit.
What was Chemcrux Enterprises' net profit in Q2 FY27?
Chemcrux Enterprises' net profit for the September 2026 quarter (Q2 FY27) was ₹0.55 crore. This is a significant increase from the ₹0.21 crore profit reported in the same quarter last year.
What was Chemcrux Enterprises' revenue in Q2 FY27?
Chemcrux Enterprises reported revenue of ₹23.84 crore for the quarter ended September 2026 (Q2 FY27). This marks an 8.7% increase from the ₹21.94 crore revenue in the preceding June 2026 quarter.
Why did Chemcrux's profit jump 162% in Q2 FY27?
Chemcrux's profit jumped 162% year-on-year primarily due to a 34% surge in revenue, driven by higher production volumes from its expanded manufacturing capacity. The growth is from a low base of ₹0.21 crore profit in Q2 FY26.
Why did Chemcrux's net profit margin stay flat QoQ at 2.3%?
Chemcrux's net profit margin was flat sequentially at 2.3% because a sharp 89% drop in other income offset the benefit of revenue growth. Industry-wide cost pressures also limited operating margin expansion in the quarter.
What caused the 88.8% plunge in other income for Chemcrux in Q2 FY27?
Chemcrux's other income fell 88.8% year-on-year to ₹0.07 crore in Q2 FY27 from ₹0.62 crore. This significant decline removed a one-off tailwind that had boosted profits in the year-ago quarter.
What is the status of Chemcrux Enterprises' debt?
According to Sharpely.in, Chemcrux Enterprises has a debt-to-equity ratio of 0.45 and an interest coverage ratio of 2.55x. This indicates a moderate level of leverage with a reasonable capacity to service its debt from operating earnings.
What guidance did Chemcrux management provide for FY27?
Management has not provided explicit forward guidance, according to an analysis by StockFin.ai. The company is focused on operational stabilization following its recent capacity expansion and governance continuity.
Is Chemcrux Enterprises undertaking any capacity expansion?
Yes. A report by StockScans notes Chemcrux completed a phased expansion in August 2024 that doubled its total reaction capability to 250 KL at its Ankleshwar plant. Its subsidiary, Kalichem, is also operational in Vadodara.
Did Chemcrux Enterprises' Q2 FY27 results beat analyst estimates?
There are no active analyst estimates or consensus forecasts available for Chemcrux Enterprises, as reported by Sharpely.in. Therefore, a comparison to estimates is not possible.
How did Chemcrux Enterprises' stock price react to the Q2 results?
Specific price action following the November 2 results announcement is not detailed in the research. The stock had fallen about 44% over the past year, as per a StockFin.ai analysis dated October 30.
Are institutional investors increasing their stake in Chemcrux?
No. According to shareholding pattern data, Foreign Institutional Investors (FII) and Domestic Institutional Investors (DII) held 0.0% stake in Chemcrux as of Q1 FY27. Promoters hold a steady 72.9%.
Chemcrux Enterprises Q2 profit drop
Chemcrux Enterprises did not report a profit drop in Q2 FY27. Its net profit increased by 161.9% year-on-year to ₹0.55 crore. The profit is, however, significantly lower than the ₹1.85 crore reported in Q4 FY26 due to margin pressures.
Chemcrux Enterprises September quarter profit
Chemcrux Enterprises reported a profit of ₹0.55 crore for the September 2026 quarter (Q2 FY27). This is a substantial increase from the ₹0.21 crore profit it posted in the September 2025 quarter.